Normal circulating immunoreactive growth hormone releasing factor (hGRF) concentrations in patients with functional hypothalamic hGRF deficiency

Clin Endocrinol (Oxf). 1986 Apr;24(4):395-400. doi: 10.1111/j.1365-2265.1986.tb01643.x.

Abstract

Using a highly specific radioimmunoassay we have measured the concentrations of human growth hormone releasing factor (ir-hGRF) in the peripheral circulation of six individuals with acquired hypothalamic hGRF deficiency. Despite their hypothalamic dysfunction venous plasma ir-hGRF increased normally in every patient after the stimulus of a mixed breakfast, from an average concentration basally of 13.6 +/- 6.0 pg/ml to a maximum of 29.0 +/- 8.4 pg/ml (mean +/- SEM) at 120 min. The findings indicate that circulating hGRF is at least in large part extrahypothalamic in origin, which in turn implies a physiological role for hGRF in the periphery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Child
  • Female
  • Growth Hormone / metabolism
  • Growth Hormone-Releasing Hormone / blood
  • Growth Hormone-Releasing Hormone / deficiency*
  • Humans
  • Hypothalamus / metabolism
  • Insulin
  • Male
  • Middle Aged
  • Peptide Fragments
  • Sermorelin

Substances

  • Insulin
  • Peptide Fragments
  • Sermorelin
  • Growth Hormone
  • Growth Hormone-Releasing Hormone